chevron_leftBack
As of 24 April 2025, Realcan Pharmaceutical Group Co., Ltd. has a market cap of $585.27M USD, ranking #11015 globally and #3387 in China. It ranks #1076 in the Healthcare sector, and #29 in the Medical Distribution industry.
Key Stats
Market Cap
$585.27MUSD
4.26B CNY
Enterprise Value
$938.93MUSD
6.84B CNY
Revenue (TTM)
$1.1BUSD
7.99B CNY
EBITDA (TTM)
$12.94MUSD
94.26M CNY
Net Income (TTM)
$5.48MUSD
39.9M CNY
EBITDA Margin
1.2%
Profit Margin
0.5%
PE Ratio
107.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Distribution
CEO
Xu Han
open_in_new
Employees
3,239
Founded
2004
Website
realcan.cn
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.4% | 0.7% | -6.2% | 2.9% | -6.5% | 17% |
Upcoming Earnings
Earnings Date
Thu, Apr 24
Today
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
002589
瑞康医药集团股份有限公司 Class A
ISIN: CNE1000013X5
Shares Out.:
Shares Outstanding:
1.151B1
Shares Float:
726.127M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
2.85 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Realcan Pharmaceutical Group Co., Ltd.
Realcan Pharmaceutical Group Co., Ltd. sells medicines, medical devices, and medical consumables to medical institution worldwide. The company operates in Drug and Equipment Distribution, Medical Diagnosis, Academic Service, Digital Medical, Pharmaceutical Logistics, and Traditional Chinese Medicine segments. It sells drugs and medical devices. The company also provides medical logistics services; third-party logistics services; health service platform; and disinfection and sterilization. The company was formerly known as Realcan Pharmaceutical Co., Ltd. and changed its name to Realcan Pharmaceutical Group Co., Ltd. in December 2018. Realcan Pharmaceutical Group Co., Ltd. was founded in 2004 and is based in Yantai, China.
